Update on diabetes mellitus: prevention, treatment, and association with oral diseases (Q37095581)

18 August 2017

title

Update on diabetes mellitus: prevention, treatment, and association with oral diseases (English)

1 reference

18 August 2017

M Skamagas

1

1 reference

18 August 2017

T L Breen

series ordinal

2

1 reference

18 August 2017

D LeRoith

series ordinal

3

1 reference

18 August 2017

publication date

1 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

14

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

105-114

1 reference

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Impaired leukocyte function in patients with poorly controlled diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

PRESERVE-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Does periodontal care improve glycemic control? The Department of Veterans Affairs Dental Diabetes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Lifetime Risk for Diabetes Mellitus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

High glucose impairs superoxide production from isolated blood neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

The World Oral Health Report 2003: continuous improvement of oral health in the 21st century--the approach of the WHO Global Oral Health Programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Repaglinide versus nateglinide monotherapy: a randomized, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Periodontal disease and mortality in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Prevalence of impacts of dental and oral disorders and their effects on eating among older people; a national survey in Great Britain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Diabetes and oral tumors in Hungary: epidemiological correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-0825.2007.01425.X

Treatment of periodontal disease in diabetics reduces glycated hemoglobin

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1902/JOP.1997.68.8.713

Identifiers

DOI

10.1111/J.1601-0825.2007.01425.X

1 reference

18 August 2017

1 reference